Research Output per year
Fingerprint Dive into the research topics where Emilia Montagna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 13 Similar Profiles
Breast Neoplasms
Medicine & Life Sciences
Estrogen Receptors
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Progesterone Receptors
Medicine & Life Sciences
Triple Negative Breast Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2005 2018
- 1860 Citations
- 22 h-Index
- 47 Article
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
International Breast Cancer Study Group Trial 23-01, Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1385-1393 9 p.Research output: Contribution to journal › Article
Neoplasm Micrometastasis
Dissection
Breast Neoplasms
Disease-Free Survival
cyhalothrin
Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes
Montagna, E., Pirola, S., Maisonneuve, P., De Roberto, G., Cancello, G., Palazzo, A., Viale, G. & Colleoni, M., Jun 2018, In : Clinical Breast Cancer. 18, 3, p. e401-e405Research output: Contribution to journal › Article
Breast Neoplasms
Lobular Carcinoma
Gastrointestinal Tract
Neoplasm Metastasis
Ductal Carcinoma
3
Citations
(Scopus)
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial
Montagna, E., Bagnardi, V., Cancello, G., Sangalli, C., Pagan, E., Iorfida, M., Mazza, M., Mazzarol, G., Dellapasqua, S., Munzone, E., Goldhirsch, A. & Colleoni, M., Jul 1 2018, In : Breast Care. 13, 3, p. 177-181 5 p.Research output: Contribution to journal › Article
Triple Negative Breast Neoplasms
Drug Therapy
Cyclophosphamide
Hand-Foot Syndrome
Safety
2
Citations
(Scopus)
Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer
Palazzo, A., Dellapasqua, S., Munzone, E., Bagnardi, V., Mazza, M., Cancello, G., Ghisini, R., Iorfida, M., Montagna, E., Goldhirsch, A. & Colleoni, M., Aug 1 2018, In : Clinical Breast Cancer. 18, 4, p. 328-335 8 p.Research output: Contribution to journal › Article
Inflammatory Breast Neoplasms
Carboplatin
Paclitaxel
Cyclophosphamide
Therapeutics
1
Citation
(Scopus)
Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?
Cazzaniga, M. E., Munzone, E., Montagna, E. & Pappagallo, G., Aug 3 2018, In : Expert Review of Anticancer Therapy. 18, 8, p. 805-814 10 p.Research output: Contribution to journal › Article
Appointments and Schedules
Breast Neoplasms
Therapeutics
Combination Drug Therapy
Pharmaceutical Preparations